Radiotherapy, Lymphopenia, and Host Immune Capacity in Glioblastoma: A Potentially Actionable Toxicity Associated With Reduced Efficacy of Radiotherapy-Reference-Cited by-同舟云学术

Radiotherapy, Lymphopenia, and Host Immune Capacity in Glioblastoma: A Potentially Actionable Toxicity Associated With Reduced Efficacy of Radiotherapy

Published:2019-06-24 Issue:4 Volume:85 Page:441-453
ISSN:0148-396X
Container-title:Neurosurgery
language:en
Short-container-title:Neurosurg.

Author:

Kleinberg Lawrence,Sloan Lindsey,Grossman Stuart,Lim Michael

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Neurology (clinical),Surgery

Link

http://academic.oup.com/neurosurgery/advance-article-pdf/doi/10.1093/neuros/nyz198/28857558/nyz198.pdf

Reference131 articles.

1. Stereotactic radiation therapy augments antigen-specific PD-1-mediated antitumor immune responses via cross-presentation of tumor antigen;Sharabi;Cancer Immunol Res,2015

2. Radiation and checkpoint blockade immunotherapy: radiosensitisation and potential mechanisms of synergy;Sharabi;Lancet Oncol,2015

3. Anti-PD-1 blockade and stereotactic radiation produce long-term survival in mice with intracranial gliomas;Zeng;Int J Radiat Oncol Biol Phys,2013

4. Radiotherapy: changing the game in immunotherapy;Demaria;Trends Cancer,2016

5. The pace of progress in radiation and immunotherapy;Formenti;Int J Radiat Oncol Biol Phys,2016

Cited by 46 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. GBM immunotherapy: Exploring molecular and clinical frontiers;Life Sciences;2024-11

2. Radiation immunodynamics in patients with glioblastoma receiving chemoradiation;Frontiers in Immunology;2024-09-13

3. Inter-subject cerebrovascular variability: a source of uncertainty for dose calculation to circulating blood cells for glioblastoma patients treated with modern radiotherapy techniques;Physics in Medicine & Biology;2024-08-21

4. An Update on the Clinical Status, Challenges, and Future Directions of Oncolytic Virotherapy for Malignant Gliomas;Current Treatment Options in Oncology;2024-06-19

5. Proton Therapy: Current Status and Controversies;JCO Oncology Practice;2024-06